16.73
前日終値:
$16.91
開ける:
$16.98
24時間の取引高:
263.40K
Relative Volume:
0.44
時価総額:
$861.85M
収益:
$107.46M
当期純損益:
$105.90M
株価収益率:
8.2511
EPS:
2.0276
ネットキャッシュフロー:
$238.50M
1週間 パフォーマンス:
-0.18%
1か月 パフォーマンス:
+4.43%
6か月 パフォーマンス:
+11.91%
1年 パフォーマンス:
+62.59%
Theravance Biopharma Inc Stock (TBPH) Company Profile
名前
Theravance Biopharma Inc
セクター
電話
650-808-6000
住所
UGLAND HOUSE, SOUTH CHURCH STREET, GEORGE TOWN, GRAND CAYMAN
Compare TBPH vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TBPH
Theravance Biopharma Inc
|
16.73 | 871.12M | 107.46M | 105.90M | 238.50M | 2.0276 |
|
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
|
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Theravance Biopharma Inc Stock (TBPH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-05 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2026-03-04 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2025-12-03 | 開始されました | Oppenheimer | Outperform |
| 2025-09-12 | 開始されました | B. Riley Securities | Buy |
| 2024-08-06 | ダウングレード | Leerink Partners | Outperform → Market Perform |
| 2024-04-12 | 開始されました | BTIG Research | Buy |
| 2024-01-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-05-23 | 開始されました | SVB Leerink | Outperform |
| 2021-11-05 | アップグレード | JP Morgan | Underweight → Neutral |
| 2021-09-15 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2021-08-25 | ダウングレード | Morgan Stanley | Overweight → Underweight |
| 2021-08-24 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-10-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-07 | 開始されました | JP Morgan | Overweight |
| 2020-06-15 | 開始されました | Morgan Stanley | Equal-Weight |
| 2020-05-13 | 開始されました | Cowen | Outperform |
| 2020-01-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-06 | アップグレード | Robert W. Baird | Underperform → Neutral |
| 2019-10-29 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-29 | 再開されました | Piper Jaffray | Overweight |
| 2017-08-17 | 開始されました | Evercore ISI | Outperform |
| 2017-06-16 | 開始されました | Cantor Fitzgerald | Overweight |
| 2017-05-11 | 繰り返されました | Needham | Buy |
| 2016-12-21 | 開始されました | Needham | Buy |
| 2016-11-03 | 開始されました | Piper Jaffray | Overweight |
| 2016-10-12 | ダウングレード | Robert W. Baird | Neutral → Underperform |
| 2016-08-03 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2016-06-20 | 開始されました | Guggenheim | Buy |
| 2016-06-20 | 繰り返されました | Leerink Partners | Outperform |
| 2016-05-12 | 開始されました | Leerink Partners | Outperform |
| 2016-05-05 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2015-02-03 | アップグレード | Robert W. Baird | Underperform → Neutral |
すべてを表示
Theravance Biopharma Inc (TBPH) 最新ニュース
MSN Money - MSN
(TBPH) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Theravance's Q4 earnings and revenues miss estimates - MSN
Theravance stock declines around 17% in three months: Here's why - MSN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc.TBPH - PR Newswire
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Theravance Biopharma, Inc.TBPH - FinancialContent
Theravance Biopharma (NASDAQ: TBPH) sets 2026 AGM votes on board, pay, auditor - Stock Titan
A Pivotal Quarter for Theravance Biopharma (TBPH): Milestone Cash Influx and a Transition to Pure Commercial Play - AlphaStreet
Theravance Biopharma (TBPH) Q4 earnings and revenues lag estimates - MSN
Here's why Theravance Biopharma (TBPH) is a strong momentum stock - MSN
Theravance Biopharma, Inc. (NASDAQ:TBPH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Laughing Water Capital Adds Theravance Biopharma to Portfolio in Q1 2026 - HarianBasis.co
Laughing Water Capital’s New Position: Theravance Biopharma, Inc. (TBPH) - Insider Monkey
Laughing Water Capital’s New Position: Theravance Biopharma (TBPH) - Yahoo Finance
Theravance and Mylan settle patent dispute with Eugia Pharma - MSN
How (TBPH) Movements Inform Risk Allocation Models - Stock Traders Daily
Theravance Biopharma (NASDAQ:TBPH) Shares Pass Below 200 Day Moving AverageHere's What Happened - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Theravance Biopharma, Inc. (TBPH) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Theravance Biopharma, Inc. (TBPH) And Encourages Shareholders to Reach Out - ACCESS Newswire
Theravance Biopharma: A Special Situation With A 50-100% Likely Upside (TBPH) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Theravance Biopharma, Inc. (TBPH) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Theravance Biopharma (TBPH) Stock: What Investors Should Know (-0.75%) 2026-04-20Buy Signals - Xã Thanh Hà
B. Riley Lifts PT on Theravance Biopharma (TBPH) to $17 From $14 - Insider Monkey
Theravance Biopharma, Inc. (TBPH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Theravance Biopharma, Inc. (TBPH) Investigation: Bronstein, Gewir - The National Law Review
Theravance Biopharma, Inc. (TBPH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Theravance Biopharma, Inc. (TBPH) Stock Analysis: Impressive Revenue Growth and Strategic Collaborations Signal Potential Upside - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Is Investigating Theravance Biopharma, Inc. (TBPH) And Encourages Investors to Connect - ACCESS Newswire
Theravance Stock Declines Around 17% in Three Months: Here's Why - Yahoo Finance
TBPH Guided for $75M in Milestones While Trial Risk Went Unquantified -- LEVI & KORSINSKY, LLP - GlobeNewswire
Theravance Biopharma Inc (TBPH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):